Induction of the von Hippel-Lindau tumor suppressor gene by late hypoxia limits HIF-1 expression

Journal of Cellular Biochemistry

Volumn 95, Issue 6, 2005, Pages 1264-1275

  Karhausen, Jörn ^a,b   Kong, Tianqing ^a   Narravula, Sailaja ^a   Colgan, Sean P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

HIF; Promoter; Transcription factor; VHL

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; PROMOTER REGIONS (GENETICS); TIME FACTORS; TRANS-ACTIVATION (GENETICS);

EID: 26444579935     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20489     Document Type: Article

References (52)

1. Baba M, Hirai S, Kawakami S, Kishida T, Sakai N, Kaneko S, Yao M, Shuin T, Kubota Y, Hosaka M, Ohno S. 2001. Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth. Oncogene 20:2727-2736.
2. Berra E, Richard DE, Gothie E, Pouyssegur J. 2001. HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation. FEES Lett 491:85-90.
3. Blagosklonny MV. 2001. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors. Oncogene 20:395-398.
4. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M. 2000. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 105:577-587.
5. Cioffi CL, Liu XQ, Kosinski PA, Garay M, Bowen BR. 2003. Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem Biophys Res Commun 303:947-953.
6. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH. 2000. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275:25733-25741.
7. Colgan SP, Dzus AL, Parkos CA. 1996. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration. J Exp Med 184:1003-1015.
8. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP. 2002. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62:3387-3394.
9. D'Angelo G, Duplan E, Boyer N, Vigne P, Frelin C. 2003. Hypoxia up-regulates prolyl hydroxylase activity: A feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem 278:38183-38187. Epub 2003 Jul 21.
10. D'Angio CT, Finkelstein JN. 2000. Oxygen regulation of gene expression: A study in opposites. Mol Genet Metab 71:371-380.
11. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford KM, Narravula S, Podolsky DK, Colgan SP. 2001. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Ex Med 193:1027-1034.
12. Hagen T, Taylor CT, Lam F, Moncada S. 2003. Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1alpha. Science 302:1975-1978.
13. Huang LE, Arany Z, Livingston DM, Bunn HF. 1996. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271:32253-32259.
14. Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Jr., Goldberg MA. 1996. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93:10595-10599.
15. Ivan M, Kaelin WG, Jr. 2001. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 11:27-34.
16. 2 sensing. Science 292:464-468.
17. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162.
18. 2-regulated prolyl hydroxylation. Science 292:468-472.
19. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. 2001. Induction of HIF-1alpha in response to hypoxia is instantaneous. Faseb J 15:1312-1314.
20. Jiang C, Lu H, Vincent KA, Shankara S, Belanger AJ, Cheng SH, Akita GY, Kelly RA, Goldberg MA, Gregory RJ. 2002. Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics 8:23-32. Epub 2001 Nov 15.
21. Kaelin WG, Jr., Maher ER. 1998. The VHL tumor-suppressor gene paradigm. Trends Genet 14:423-426.
22. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. 1999. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274:6519-6525.
23. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, Esumi H. 2001. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276:2292-2298.
24. Kuzmin I, Duh FM, Latif F, Geil L, Zbar B, Lerman MI. 1995. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 10:2185-2194.
25. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. 2002a. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466-1471.
26. Lando D, Peet DJ, Whelan DA, Gorman JJ, Murray LW. 2002b. Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch. Science 295:858-861.
27. Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO, Zhuang Z. 1998. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58:504-508.
28. Li Z, Wang D, Na X, Schoen SR, Messing EM, Wu G. 2003. The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity. Embo J 22:1857-1867.
29. Linehan WM, Lerman MI, Zbar B. 1995. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. Jama 273:564-570.
30. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680.
31. Mahon PC, Hirota K, Semenza GL. 2001. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15:2675-2686.
32. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P, Metzen E. 2004. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 381:761-767.
33. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
34. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP. 1997. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol 17:5629-5639.
35. Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG, Jr., Iliopoulos O. 1998. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1:959-968.
36. Paul SA, Simons JW, Mabjeesh NJ. 2004. HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol 200:20-30.
37. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:E45.
38. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR. 2002. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2:81-91.
39. Salnikow K, Kluz T, Costa M, Piquemal D, Demidenko ZN, Xie K, Blagosklonny MV. 2002. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol 22:1734-1741.
40. Schofield CJ, Ratcliffe PJ. 2004. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5:343-354.
41. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
42. Semenza GL. 2004. Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell 5:405-406.
43. Sheta EA, Trout H, Gildea JJ, Harding MA, Theodorescu D. 2001. Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene 20:7624-7634.
44. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D. 2001. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. Faseb J 15:2445-2453.
45. Suske G. 1999. The Sp-family of transcription factors. Gene 238:291-300.
46. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 (HIF-1) mediates permeability changes in intestinal epithelia. J Clin Invest 110:993-1002.
47. Taylor CT, Fueki N, Agah A, Hershberg RM, Colgan SP. 1999. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial TNFa. J Biol Chem 274:19447-19450.
48. Taylor CT, Furuta GT, Synnestvedt K, Colgan SP. 2000. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc Natl Acad Sci USA 97:12091-12096.
49. Turcotte S, Desrosiers RR, Beliveau R. 2004. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma. Am J Physiol Renal Physiol 286:F338-F348. Epub 2003 Oct 28.
50. Wang GL, Semenza GL. 1995. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270:1230-1237.
51. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. 2000. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene 19:6297-6305.
52. Zatyka M, Morrissey C, Kuzmin I, Lerman MI, Latif F, Richards FM, Maher ER. 2002. Genetic and functional analysis of the von Hippel-Lindau (VHL) tumor suppressor gene promoter. J Med Genet 39:463-472.